Search results for: 'biologics contract development'

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

The growing global demand for sustainable and ethical food sources has led to significant advancements in alternative proteins. From plant-based proteins to cellular agriculture and novel fermentation techniques, researchers and industry pioneers are leveraging biotechnology, data analytics, and process optimization to enhance the efficiency and sc...

28 Jul 2021  |  Global  |  Market Research

Global Pharmaceutical Packaging Materials Growth Opportunities

Future Growth Potential Enhanced by Increasing Development of Complex Biologics

Infographics

×

The pharmaceutical packaging materials market comprises the following segments: plastic, glass, and others, which includes aluminum, rubber, and paper. By end-product type, the market has been divided into oral drugs, drops and sprays, topical medicines and suppositories, and injectables. Packaging plays a pivotal role in the pharmaceutical indus...

Radical changes in science and technology are helping the human body evolve. Biological augmentations and body enhancements are transforming the human body and bringing about a kind of transhumanism by eliminating diseases, extending life spans, and enhancing human capabilities. Biological augmentations and body enhancements are classified into th...

According to the International Energy Agency (IEA), the aviation industry accounts for 2% of global carbon emissions. Total cumulative emissions reached approximately 800 million tons in 2022, and cumulative emissions are expected to reach approximately 1,750-2,000 million tons by 2050. The International Air Transport Association (IATA) has committ...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

Buildings are becoming more energy-intensive and with features like electric vehicle charging adding to the existing load, the need to reduce energy consumption acquires an even greater importance. Energy saving and performance contracting (ESPC) is one way to achieve energy efficiency. In that sense, North America has been the second-largest marke...

This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key marke...